Drugs interactions for Victoza ®
- 0 Major drug interactions
- 255 Moderate drug interactions (including ingredients like Acarbose, Acebutolol, Acetylsalicylic acid)
- 38 Minor drug interactions (including ingredients like Acetazolamide, Acetyl sulfisoxazole, Albuterol)
293 interactions for Victoza ®The risk or severity of hypoglycemia can be increased when Acarbose is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Acebutolol.The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Alogliptin.The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Liraglutide.Aminosalicylic acid may increase the hypoglycemic activities of Liraglutide.The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Liraglutide.Amitriptyline may decrease the hypoglycemic activities of Liraglutide.The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Liraglutide.Amoxapine may decrease the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Aripiprazole.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Arsenic trioxide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Articaine.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Asenapine.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Atazanavir.The therapeutic efficacy of Liraglutide can be increased when used in combination with Atenolol.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Baclofen.Balsalazide may increase the hypoglycemic activities of Liraglutide.The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Benazepril is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Bendroflumethiazide.The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Betaxolol.Bexagliflozin may increase the hypoglycemic activities of Liraglutide.Bismuth subsalicylate may increase the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Bisoprolol.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Brexpiprazole.The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Bromocriptine.The risk or severity of hyperglycemia can be increased when Budesonide is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Bumetanide.Canagliflozin may increase the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Carvedilol.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Ceritinib.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Chlorothiazide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Chlorpromazine.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Chlorthalidone.Choline salicylate may increase the hypoglycemic activities of Liraglutide.The risk or severity of hyperglycemia can be increased when Ciclesonide is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Ciprofloxacin.The risk or severity of hypoglycemia can be increased when Citalopram is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Clevidipine is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Liraglutide.Clomipramine may decrease the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Clozapine.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Conjugated estrogens.The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Dabrafenib.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Danazol.Dapagliflozin may increase the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Darunavir.The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Delafloxacin.Desipramine may decrease the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Desogestrel.The risk or severity of hyperglycemia can be increased when Desonide is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Desoximetasone is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Desvenlafaxine is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Dexamethasone acetate is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Diazoxide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Dienogest.The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Liraglutide.Diflunisal may increase the hypoglycemic activities of Liraglutide.The risk or severity of hyperglycemia can be increased when Difluprednate is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Disopyramide is combined with Liraglutide.Doxepin may decrease the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Drospirenone.The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Dulaglutide.The risk or severity of hypoglycemia can be increased when Duloxetine is combined with Liraglutide.Empagliflozin may increase the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Epinephrine.Ertugliflozin may increase the hypoglycemic activities of Liraglutide.The risk or severity of hypoglycemia can be increased when Escitalopram is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Estetrol.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Estradiol.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Estrone sulfate.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Etacrynic acid.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Ethinylestradiol.The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Ethynodiol diacetate.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Etonogestrel.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Everolimus.The risk or severity of hypoglycemia can be increased when Exenatide is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Felodipine is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Fluconazole.The risk or severity of hyperglycemia can be increased when Fludrocortisone is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Fluocinolone acetonide is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Fluocinonide is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Fluoxetine is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Flurandrenolide is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Fluvoxamine is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Fosamprenavir.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Furosemide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Gatifloxacin.The therapeutic efficacy of Liraglutide can be increased when used in combination with Gemifloxacin.Liraglutide may increase the hypoglycemic activities of Glimepiride.Liraglutide may increase the hypoglycemic activities of Glipizide.Liraglutide may increase the hypoglycemic activities of Glyburide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Goserelin.The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Haloperidol.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Histrelin.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Hydrochlorothiazide.The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Hydroflumethiazide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Hydroxychloroquine.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Hydroxyprogesterone caproate.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Iloperidone.Imipramine may decrease the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Indapamide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Indinavir.The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Liraglutide.Liraglutide may increase the hypoglycemic activities of Insulin aspart.Liraglutide may increase the hypoglycemic activities of Insulin detemir.Liraglutide may increase the hypoglycemic activities of Insulin glargine.Liraglutide may increase the hypoglycemic activities of Insulin glulisine.Liraglutide may increase the hypoglycemic activities of Insulin human.Liraglutide may increase the hypoglycemic activities of Insulin lispro.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Isoniazid.The risk or severity of hypoglycemia can be increased when Isradipine is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Labetalol.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Lanreotide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Leuprolide.The risk or severity of hypoglycemia can be increased when Levamlodipine is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Levofloxacin.The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Levonorgestrel.The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Linagliptin.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Liothyronine.The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Lixisenatide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Lomefloxacin.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Lonapegsomatropin.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Lopinavir.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Lurasidone.The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Mecasermin is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Medroxyprogesterone acetate.The risk or severity of hyperglycemia can be increased when Medrysone is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Megestrol acetate.Mesalazine may increase the hypoglycemic activities of Liraglutide.The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Metformin.The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Liraglutide.Methyl salicylate may increase the hypoglycemic activities of Liraglutide.The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Metolazone.The therapeutic efficacy of Liraglutide can be increased when used in combination with Metoprolol.The risk or severity of hypoglycemia can be increased when Mifepristone is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Miglitol is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Milnacipran is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Moxifloxacin.The therapeutic efficacy of Liraglutide can be increased when used in combination with Nadolol.The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Nebivolol.The risk or severity of hypoglycemia can be increased when Nefazodone is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Nelfinavir.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Niacin.The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Nifedipine is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Nilotinib.The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Norethisterone.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Norgestimate.Nortriptyline may decrease the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Octreotide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Ofloxacin.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Olanzapine.Olsalazine may increase the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Paliperidone.The risk or severity of hypoglycemia can be increased when Paroxetine is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Pasireotide.The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Pentamidine.The therapeutic efficacy of Liraglutide can be increased when used in combination with Phentermine.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Phenytoin.The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Pindolol.The risk or severity of hypoglycemia can be increased when Pioglitazone is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Polythiazide.The risk or severity of hypoglycemia can be increased when Pramlintide is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Prednicarbate is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Prednisolone phosphate is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Prednisone is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Progesterone.The therapeutic efficacy of Liraglutide can be increased when used in combination with Propafenone.The therapeutic efficacy of Liraglutide can be increased when used in combination with Propranolol.Protriptyline may decrease the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Pseudoephedrine.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Quetiapine.The risk or severity of hypoglycemia can be increased when Quinine is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Risperidone.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Ritonavir.The risk or severity of hypoglycemia can be increased when Rosiglitazone is combined with Liraglutide.Salicylic acid may increase the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Saquinavir.The risk or severity of hypoglycemia can be increased when Saxagliptin is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Semaglutide.The risk or severity of hypoglycemia can be increased when Sertraline is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Sirolimus.The risk or severity of hypoglycemia can be increased when Sitagliptin is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Somapacitan.Somatotropin may decrease the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Somatrogon.The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Sotagliflozin.The risk or severity of hypoglycemia can be increased when Sotalol is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Sulfadiazine is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Sulfamethoxazole is combined with Liraglutide.Sulfasalazine may increase the hypoglycemic activities of Liraglutide.The risk or severity of hypoglycemia can be increased when Sunitinib is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Tacrolimus.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Temsirolimus.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Teprotumumab.Thyroid, porcine may decrease the hypoglycemic activities of Liraglutide.Thyrotropin alfa may decrease the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Timolol.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Tipranavir.The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Tirzepatide.The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Liraglutide.Liraglutide may increase the hypoglycemic activities of Tolazamide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Torasemide.The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Liraglutide.Trimipramine may decrease the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Triptorelin.Trolamine salicylate may increase the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Trovafloxacin.The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Liraglutide.The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Verapamil is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Vorinostat.The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Liraglutide.The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Ziprasidone.The risk or severity of hypoglycemia can be increased when Zonisamide is combined with Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Acetazolamide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Acetyl sulfisoxazole.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Albuterol.The therapeutic efficacy of Liraglutide can be increased when used in combination with Bosentan.The therapeutic efficacy of Liraglutide can be increased when used in combination with Celecoxib.The therapeutic efficacy of Liraglutide can be increased when used in combination with Diclofenamide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Fedratinib.Fluoxymesterone may increase the hypoglycemic activities of Liraglutide.Isocarboxazid may increase the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Levothyroxine.Linezolid may increase the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be decreased when used in combination with Lithium carbonate.The therapeutic efficacy of Liraglutide can be increased when used in combination with Methazolamide.Methylene blue may increase the hypoglycemic activities of Liraglutide.Methyltestosterone may increase the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Mitapivat.Nandrolone decanoate may increase the hypoglycemic activities of Liraglutide.Oxandrolone may increase the hypoglycemic activities of Liraglutide.Oxymetholone may increase the hypoglycemic activities of Liraglutide.Phenelzine may increase the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Probenecid.Procaine may increase the hypoglycemic activities of Liraglutide.Procarbazine may increase the hypoglycemic activities of Liraglutide.Rasagiline may increase the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Rosuvastatin.Safinamide may increase the hypoglycemic activities of Liraglutide.Selegiline may increase the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Sulfamethizole.The therapeutic efficacy of Liraglutide can be increased when used in combination with Sumatriptan.The therapeutic efficacy of Liraglutide can be increased when used in combination with Tamsulosin.Testosterone may increase the hypoglycemic activities of Liraglutide.Testosterone cypionate may increase the hypoglycemic activities of Liraglutide.Testosterone enanthate may increase the hypoglycemic activities of Liraglutide.Testosterone propionate may increase the hypoglycemic activities of Liraglutide.Testosterone undecanoate may increase the hypoglycemic activities of Liraglutide.Tranylcypromine may increase the hypoglycemic activities of Liraglutide.The therapeutic efficacy of Liraglutide can be increased when used in combination with Valdecoxib.The therapeutic efficacy of Liraglutide can be increased when used in combination with Vemurafenib.
A therapy excluded from this list of known interactions does not necessarily mean that no interactions exist between that therapy and and Victoza ®.
Acarbose
Acebutolol
Acetylsalicylic acid
Alclometasone
Alogliptin
Amcinonide
Aminosalicylic acid
Amiodarone
Amitriptyline
Amlodipine
Amoxapine
Aripiprazole
Arsenic trioxide
Articaine
Asenapine
Atazanavir
Atenolol
Baclofen
Balsalazide
Beclomethasone dipropionate
Benazepril
Bendroflumethiazide
Betamethasone
Betaxolol
Bexagliflozin
Bismuth subsalicylate
Bisoprolol
Brexpiprazole
Bromocriptine
Budesonide
Bumetanide
Canagliflozin
Carvedilol
Ceritinib
Chlorothiazide
Chlorpromazine
Chlorthalidone
Choline salicylate
Ciclesonide
Ciprofloxacin
Citalopram
Clevidipine
Clobetasol propionate
Clocortolone
Clomipramine
Clozapine
Conjugated estrogens
Corticotropin
Cortisone acetate
Dabrafenib
Danazol
Dapagliflozin
Darunavir
Deflazacort
Delafloxacin
Desipramine
Desogestrel
Desonide
Desoximetasone
Desvenlafaxine
Dexamethasone
Dexamethasone acetate
Diazoxide
Dienogest
Diflorasone
Diflunisal
Difluprednate
Diltiazem
Disopyramide
Doxepin
Drospirenone
Dulaglutide
Duloxetine
Empagliflozin
Epinephrine
Ertugliflozin
Escitalopram
Estetrol
Estradiol
Estrone sulfate
Etacrynic acid
Ethinylestradiol
Ethosuximide
Ethynodiol diacetate
Etonogestrel
Everolimus
Exenatide
Felodipine
Fluconazole
Fludrocortisone
Flunisolide
Fluocinolone acetonide
Fluocinonide
Fluorometholone
Fluoxetine
Flurandrenolide
Fluticasone furoate
Fluticasone propionate
Fluvoxamine
Fosamprenavir
Furosemide
Gatifloxacin
Gemifloxacin
Glimepiride
Glipizide
Glyburide
Goserelin
Halcinonide
Haloperidol
Histrelin
Hydrochlorothiazide
Hydrocortisone
Hydrocortisone acetate
Hydrocortisone butyrate
Hydrocortisone probutate
Hydrocortisone succinate
Hydrocortisone valerate
Hydroflumethiazide
Hydroxychloroquine
Hydroxyprogesterone caproate
Iloperidone
Imipramine
Indapamide
Indinavir
Indomethacin
Insulin aspart
Insulin detemir
Insulin glargine
Insulin glulisine
Insulin human
Insulin lispro
Isoniazid
Isradipine
Labetalol
Lanreotide
Leuprolide
Levamlodipine
Levofloxacin
Levomilnacipran
Levonorgestrel
Linagliptin
Liothyronine
Lipoic acid
Lixisenatide
Lomefloxacin
Lonapegsomatropin
Lopinavir
Lurasidone
Magnesium sulfate
Mecasermin
Medroxyprogesterone acetate
Medrysone
Megestrol acetate
Mesalazine
Metformin
Methsuximide
Methyl salicylate
Methylprednisolone
Methylprednisolone hemisuccinate
Metolazone
Metoprolol
Mifepristone
Miglitol
Milnacipran
Mometasone furoate
Moxifloxacin
Nadolol
Nateglinide
Nebivolol
Nefazodone
Nelfinavir
Niacin
Nicardipine
Nifedipine
Nilotinib
Nimodipine
Nisoldipine
Norethisterone
Norgestimate
Nortriptyline
Octreotide
Ofloxacin
Olanzapine
Olsalazine
Paliperidone
Paroxetine
Pasireotide
Pegvisomant
Pentamidine
Phentermine
Phenytoin
Pinaverium
Pindolol
Pioglitazone
Polythiazide
Pramlintide
Prednicarbate
Prednisolone
Prednisolone acetate
Prednisolone phosphate
Prednisone
Pregabalin
Progesterone
Propafenone
Propranolol
Protriptyline
Pseudoephedrine
Quetiapine
Quinine
Repaglinide
Risperidone
Ritonavir
Rosiglitazone
Salicylic acid
Saquinavir
Saxagliptin
Semaglutide
Sertraline
Sirolimus
Sitagliptin
Somapacitan
Somatotropin
Somatrogon
Sotagliflozin
Sotalol
Sulfadiazine
Sulfamethoxazole
Sulfasalazine
Sunitinib
Tacrolimus
Temsirolimus
Teprotumumab
Thyroid, porcine
Thyrotropin alfa
Timolol
Tipranavir
Tirzepatide
Tixocortol
Tolazamide
Torasemide
Triamcinolone
Trimipramine
Triptorelin
Trolamine salicylate
Trovafloxacin
Ubidecarenone
Ulobetasol
Vamorolone
Venlafaxine
Verapamil
Vorinostat
Xylometazoline
Ziconotide
Ziprasidone
Zonisamide
Acetazolamide
Acetyl sulfisoxazole
Albuterol
Bosentan
Celecoxib
Diclofenamide
Fedratinib
Fluoxymesterone
Isocarboxazid
Levothyroxine
Linezolid
Lithium carbonate
Methazolamide
Methylene blue
Methyltestosterone
Mitapivat
Nandrolone decanoate
Oxandrolone
Oxymetholone
Phenelzine
Probenecid
Procaine
Procarbazine
Rasagiline
Rosuvastatin
Safinamide
Selegiline
Sulfamethizole
Sumatriptan
Tamsulosin
Testosterone
Testosterone cypionate
Testosterone enanthate
Testosterone propionate
Testosterone undecanoate
Tranylcypromine
Valdecoxib
Vemurafenib